HOWARD I RUTMAN, MD
Osteopathic Medicine at 210 St, Bronx, NY
License number
New York 150497
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
2
111 EAST 210Th St, Bronx, NY 10467
401 E 80Th St, New York, NY 10021
401 E 80Th St, New York, NY 10021
Phone
(718) 405-8477
(718) 405-8476 (Fax)
(718) 405-8476 (Fax)
Personal information
See more information about HOWARD I RUTMAN at radaris.comName
Address
Phone
New York, NY
65 96 At Madison, New York, NY 10001
65 96Th St, New York, NY 10128
65 96Th St, New York, NY 10128
401 80Th St, New York, NY 10001
Organization information
See more information about HOWARD I RUTMAN at bizstanding.comHoward I Rutman MD
New York, NY
Industry:
Nonclassifiable Establishments
Addresses:
201 E 77 St, New York, NY 10075
401 E 80 St, New York, NY 10075
401 E 80 St, New York, NY 10075
Medical Doctor:
Howard Rutman (Medical Doctor)
HOWARD I. RUTMAN, M.D., PC
65 E 96 St, New York, NY 10128
Status:
Inactive
Doing business as:
Howard I Rutman MD
Inactive reason:
Dissolution
Registration:
Mar 12, 1997
Inactive since:
Jun 28, 2007
Phone:
(212) 860-8600 (Phone)
State ID:
2122296
Business type:
DOMESTIC PROFESSIONAL CORPORATION
Howard I Rutman, 65 E 96 St, New York, NY 10128 (Physical)
Categories:
Cardiology Physicians & Surgeons, Physicians & Surgeons
Professional information
Group Vice President, Medical Director At Taro Pharmaceuticals
Position:
Group Vice President, Medical Director at Taro Pharmaceuticals, Attending at Mount Sinai School of Medicine, Cardiology Attending at Albert Einstein College of Medicine
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
Taro Pharmaceuticals
since Apr 2003
-
Group Vice President, Medical Director
Mount Sinai School of Medicine
since Jul 1988
-
Attending
Albert Einstein College of Medicine
since Jun 1986
-
Cardiology Attending
Montefiore Hospital
Jul 1986 - Apr 2007
-
Attending
Education:
New York University - Leonard N. Stern School of Business 2000 - 2002
MBA, Management The Johns Hopkins University School of Medicine 1977 - 1981
MD Harvard University 1973 - 1977
AB, Biochemical Sciences
MBA, Management The Johns Hopkins University School of Medicine 1977 - 1981
MD Harvard University 1973 - 1977
AB, Biochemical Sciences
Dr. Howard I Rutman, Bronx NY - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
Division of Cardiology-Montefiore-Einstein
111 E 210Th St, Bronx 10467
(718) 920-5528 (Phone)
65 E 96Th St, New York 10128
(212) 426-7300 (Phone)
111 E 210Th St, Bronx 10467
(718) 920-5528 (Phone)
65 E 96Th St, New York 10128
(212) 426-7300 (Phone)
Conditions:
Arrhythmias (incl. Atrial Fibrillation), Hypertension, Mitral Valve Disease
Certifications:
Cardiovascular Disease, 1987, Internal Medicine, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Division of Cardiology-Montefiore-Einstein
111 E 210Th St, Bronx 10467
65 E 96Th St, New York 10128
Montefiore Medical Center
111 East 210Th St, Bronx 10467
111 E 210Th St, Bronx 10467
65 E 96Th St, New York 10128
Montefiore Medical Center
111 East 210Th St, Bronx 10467
Education:
Medical School
Johns Hopkins University School Of Medicine
Graduated: 1981
Ny Hosp/Cornell Med Center
Graduated: 1984
Einstein
Graduated: 1986
Johns Hopkins University School Of Medicine
Graduated: 1981
Ny Hosp/Cornell Med Center
Graduated: 1984
Einstein
Graduated: 1986
Topical Gel Formulation Comprising Organophosphate Insecticide And Preparation Thereof
US Patent:
8012498, Sep 6, 2011
Filed:
Jul 12, 2005
Appl. No.:
11/179719
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NY, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NY, US
International Classification:
A01N 57/10, A01N 57/12, A61K 9/06, A61K 31/661, A61K 47/38, A61P 33/14
US Classification:
424405, 424407, 514122, 514781
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0. 1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.
Topical Gel Formulation Comprising Organophosphate Insecticide And Preparation Thereof
US Patent:
2012005, Mar 1, 2012
Filed:
Aug 30, 2011
Appl. No.:
13/220935
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Assignee:
Taro Pharmaceuticals North America, Inc. - Grand Cayman
International Classification:
A61K 31/6615, A61P 33/14
US Classification:
514122
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.
Topical Gel Formulation Comprising Organophosphate Insecticide And Preparation Thereof
US Patent:
8158139, Apr 17, 2012
Filed:
Feb 9, 2006
Appl. No.:
11/351188
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Latchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Subhas Kundu - Tappan NY, US
Daniel Moros - Latchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Assignee:
Taro Pharmaceuticals North America, Inc. - Grand Cayman
International Classification:
A01N 57/10, A01N 57/12, A01N 25/02, A61K 9/08, A61K 31/661, A61K 47/10, A61K 47/14, A61P 33/14
US Classification:
424405, 514122, 514786
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0. 1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present topical formulations encompass a non-flammable solvent for malathion effective in killing head lice. The present gel pharmaceutical formulation preferably contains malathion and optionally contains isopropyl myristate. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.
Composition And Method For Improved Bioavailability And Enhanced Brain Delivery Of 5,5-Diphenyl Barbituric Acid
US Patent:
8076346, Dec 13, 2011
Filed:
Jan 19, 2010
Appl. No.:
12/689757
Inventors:
Daniella Gutman - Rishon Lezion, IL
Barrie Levitt - Mamaroneck NY, US
Daniel A. Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
Barrie Levitt - Mamaroneck NY, US
Daniel A. Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
Assignee:
Taro Pharamaceutical Industries Ltd. - Haifa Bay
International Classification:
A61K 31/515, C07D 239/64
US Classification:
514270, 544305
Abstract:
The present invention relates to a composition and a method of delivering a barbituric acid derivative to the central nervous system of a mammal in need of treatment for neurological conditions. In particular, the present invention relates to a method of administering an oral dosage form of a sodium salt of 5,5-diphenyl barbituric acid to enhance the bioavailability of 5,5-diphenyl barbituric acid and brain delivery of same.
Composition And Method For Improved Bioavailability And Enhanced Brain Delivery Of 5,5-Diphenyl Barbituric Acid
US Patent:
2006012, Jun 8, 2006
Filed:
Aug 10, 2005
Appl. No.:
11/201024
Inventors:
Daniella Gutman - Rishon Lezion, IL
Daniel Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
Daniel Moros - Larchmont NY, US
Avraham Yacobi - Englewood NJ, US
Howard Rutman - New York NY, US
International Classification:
A61K 31/515
US Classification:
514270000
Abstract:
The present invention relates to a composition and a method of delivering a barbituric acid derivative to the central nervous system of a mammal in need of treatment for neurological conditions. In particular, the present invention relates to a method of administering an oral dosage form of a sodium salt of 5,5-diphenyl barbituric acid to enhance the bioavailability of 5,5-diphenyl barbituric acid and brain delivery of same.
Topical Gel Formulation Comprising Insecticide And Its Preparation Thereof
US Patent:
2006012, Jun 8, 2006
Filed:
Jul 12, 2005
Appl. No.:
11/179924
Inventors:
Sandhya Goyal - Ryebrook NY, US
Subhas Kundus - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
Subhas Kundus - Tappan NY, US
Daniel Moros - Larchmont NY, US
Howard Rutman - New York NY, US
Avraham Yacobi - Englewood NJ, US
International Classification:
A01N 65/00, A01N 25/00, A01N 43/04, A01N 55/00, A01N 43/30, A01N 29/04
US Classification:
424405000, 514028000, 514065000, 514063000, 514464000, 514747000
Abstract:
The present invention provides a topical gel pharmaceutical formulation of insecticide suitable for treating an ectoparasite in a mammal, comprising: a) about 0.1-10% by weight of an insecticide; b) at least about 75% by weight of an organic solvent selected from the group consisting of a lower alkyl alcohol, a ketone, a glycol and a mixture thereof, wherein the organic solvent contains at least about 40% by weight of the lower alkyl alcohol; and c) at least one polymer selected from the group consisting of a cellulosic polymer, acrylates, methacrylates, and polyvinyl pyrrolidone. The present invention further provides a process of preparing as well as a method of treating ectoparasites in a mammal using the same.